⌘K
t
BioPharma Credit PLC announced on 10 April 2026 that its Investment Adviser, Pharmakon Advisors, LP, will provide a live investor presentation. This event is scheduled for 21 April 2026 at 15:00 BST via Investor Meet Company, with pre-event questions accepted until 20 April 2026 at 09:00am BST.
| Date | 10 Apr 2026 |
| Time | 07:00:06 |
| Category | Miscellaneous |
| ID | 9002Z |
10 April 2026
BioPharma Credit PLC
(the "Company")
Investor Presentation via Investor Meet Company
BioPharma Credit PLC announces that the Company's Investment Adviser, Pharmakon Advisors, LP, will provide a live presentation via Investor Meet Company on 21 April 2026 at 15:00 BST.
The presentation is open to existing and potential shareholders and will provide an overview of the Company's investment strategy and portfolio.
Questions can be submitted pre-event via your Investor Meet Company dashboard up until 20 April 2026 at 09:00am BST, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet the Company via:
https://www.investormeetcompany.com/biopharma-credit-plc/register-investor
Investors who already follow the Company on the Investor Meet Company platform will automatically be invited.
- ENDS -
For further information:
Enquiries:
BioPharma Credit plc
via MUFG Corporate Governance Limited
Company Secretary
+44 (0) 333 300 1932
Burson Buchanan
Henry Wilson / Helen Tarbet / Jamie Hooper / Nick Croysdill
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.